The device center says it plans to re-issue its draft guidance on the investigation device exemption process in response to recently enacted restrictions from Congress.
FDA To Re-Issue Draft Guidance On Investigational Device Exemption Standards
The device center is responding to a provision in the FDA Safety and Innovation Act, passed last summer, which explicitly prohibits FDA from disapproving an IDE solely because the agency does not believe the study could support approval or clearance.